ボア大王🩷

[ボア大王🩷 @ntlaguy]

https://t.co/qA4GT8jrX7

[ボア大王🩷 @ntlaguy]

よくわからない奴らにマック奢る夢みたわ

[ボア大王🩷 @ntlaguy]

なんか今燃えてんだか騒がれてる猫耳女の人のアクションがどうも昔の外国アニメの人間っぽい動きする動物みたく見えるのよな

[ボア大王🩷 @ntlaguy]

仕事で疲れて帰ってくる夫をおっぱいで癒す妻のブランシェルナ
おっぱいテラピーが毎日の癒し

[ボア大王🩷 @ntlaguy]

まぁ人減らしでしょ
リモートで会社来れませんってよくよく考えたら要らない

[ボア大王🩷 @ntlaguy]

かんなさん報酬ありがとう完凸します

[ボア大王🩷 @ntlaguy]

ASAMAでハロウィン

[ボア大王🩷 @ntlaguy]

先車、後ろに猫って感じ

[ボア大王🩷 @ntlaguy]

久々にアニソン歌ったりしてるけど高ぇ

[ボア大王🩷 @ntlaguy]

週末4連休だしプラグイン調べてつくろ

[ボア大王🩷 @ntlaguy]

$MTVA drops spectacular Ph1 MAD data: 6.3% max WL @ 26d, no titration, clean tolerability. Outpacing $VKTX (4%/28d) & $AMGN (7.2%/85d). Dual GLP-1/GCGR shows glucose ↓18 mg/dL + 3.9" waist. Best-in-class potential. $15M cap. Quiet no more.

[ボア大王🩷 @ntlaguy]

$MTVA and Dong-A ST microneedle patch for obesity 🤯 4/16 🤫

[ボア大王🩷 @ntlaguy]

$MTVA This might be fun 😉

[ボア大王🩷 @ntlaguy]

$MTVA 17 Days https://t.co/c08Z1YCKQ3

[ボア大王🩷 @ntlaguy]

$MTVA 💪🤑

[ボア大王🩷 @ntlaguy]

$MTVA $23🤑

[ボア大王🩷 @ntlaguy]

$MTVA Is anyone going to the Dong-A ST shareholders' meeting on the 31st? I would like updates please 😁

[ボア大王🩷 @ntlaguy]

$MTVA If the MAD trial shows strong tolerability + weight reduction:

Expect a major valuation re-rate
Possible strategic interest or buyout
S-1 and S-8 filings ensure legal + structural readiness for volatility, liquidity, and retention

Smart setup. Big moment coming.

[ボア大王🩷 @ntlaguy]

$MTVA MetaVia Preps for DA-1726 Data with Strategic SEC Moves

MetaVia just filed a Post-Effective Amendment (S-1) and a Form S-8 on March 27—days before expected DA-1726 Phase 1 MAD top-line results in April.

[ボア大王🩷 @ntlaguy]

Why it matters: DA-1726 is a dual GLP-1/glucagon agonist that boosts basal metabolic rate, potentially outperforming sema/tirze. In preclinical obese models, it achieved superior weight loss despite increased intake.